RU2001128507A - Fertility Improving Compositions - Google Patents
Fertility Improving CompositionsInfo
- Publication number
- RU2001128507A RU2001128507A RU2001128507/14A RU2001128507A RU2001128507A RU 2001128507 A RU2001128507 A RU 2001128507A RU 2001128507/14 A RU2001128507/14 A RU 2001128507/14A RU 2001128507 A RU2001128507 A RU 2001128507A RU 2001128507 A RU2001128507 A RU 2001128507A
- Authority
- RU
- Russia
- Prior art keywords
- inhibitor
- dipeptidyl peptidase
- composition according
- infertility
- improving compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 6
- 230000035558 fertility Effects 0.000 title claims 3
- 208000000509 Infertility Diseases 0.000 claims 4
- 239000003603 dipeptidyl peptidase IV inhibitor Substances 0.000 claims 4
- 230000036512 infertility Effects 0.000 claims 4
- 231100000535 infertility Toxicity 0.000 claims 4
- 230000002708 enhancing Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 1
- 230000004720 fertilization Effects 0.000 claims 1
- 150000002825 nitriles Chemical class 0.000 claims 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 claims 1
- 230000001737 promoting Effects 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 claims 1
Claims (7)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9906714.2A GB9906714D0 (en) | 1999-03-23 | 1999-03-23 | Compositions for improving fertility |
GB9906714.2 | 1999-03-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2001128507A true RU2001128507A (en) | 2003-06-27 |
RU2246944C2 RU2246944C2 (en) | 2005-02-27 |
Family
ID=10850229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001128507/15A RU2246944C2 (en) | 1999-03-23 | 2000-03-21 | Fertility improving compositions |
Country Status (29)
Country | Link |
---|---|
US (1) | US7115650B1 (en) |
EP (1) | EP1162969B1 (en) |
JP (1) | JP2002539243A (en) |
KR (1) | KR100689951B1 (en) |
CN (1) | CN1196483C (en) |
AR (1) | AR023129A1 (en) |
AT (1) | ATE328594T1 (en) |
AU (1) | AU765912B2 (en) |
CA (1) | CA2366911C (en) |
CZ (1) | CZ20013410A3 (en) |
DE (1) | DE60028552T2 (en) |
DK (1) | DK1162969T3 (en) |
ES (1) | ES2265918T3 (en) |
GB (1) | GB9906714D0 (en) |
HK (1) | HK1046647B (en) |
HU (1) | HUP0200410A3 (en) |
IL (1) | IL145569A0 (en) |
MX (1) | MXPA01009612A (en) |
MY (1) | MY135683A (en) |
NO (1) | NO20014607L (en) |
NZ (1) | NZ514449A (en) |
PL (1) | PL195779B1 (en) |
PT (1) | PT1162969E (en) |
RU (1) | RU2246944C2 (en) |
TR (1) | TR200102647T2 (en) |
TW (1) | TWI244920B (en) |
UA (1) | UA77644C2 (en) |
WO (1) | WO2000056296A2 (en) |
ZA (1) | ZA200108083B (en) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6979697B1 (en) | 1998-08-21 | 2005-12-27 | Point Therapeutics, Inc. | Regulation of substrate activity |
GB9928330D0 (en) * | 1999-11-30 | 2000-01-26 | Ferring Bv | Novel antidiabetic agents |
US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
US6512120B1 (en) | 2001-03-12 | 2003-01-28 | Ortho Mcneil Pharmaceutical, Inc. | Methods for the synthesis of densely functionalized pyrrolidine intermediates |
GB0109146D0 (en) * | 2001-04-11 | 2001-05-30 | Ferring Bv | Treatment of type 2 diabetes |
HUP0400321A2 (en) | 2001-06-27 | 2004-08-30 | Smithkline Beecham Corp. | Fluoropyrrolidines as dipeptidyl peptidase inhibitors and pharmaceutical compositions containing them |
DE60223920T2 (en) | 2001-06-27 | 2008-11-13 | Smithkline Beecham Corp. | PYRROLIDINES AS DIPEPTIDYL-PEPTIDASE INHIBITORS |
US7183290B2 (en) | 2001-06-27 | 2007-02-27 | Smithkline Beecham Corporation | Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
EP1338595B1 (en) | 2002-02-25 | 2006-05-03 | Eisai Co., Ltd. | Xanthine derivatives as DPP-IV inhibitors |
US6710040B1 (en) | 2002-06-04 | 2004-03-23 | Pfizer Inc. | Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors |
EP1514552A4 (en) | 2002-06-06 | 2008-04-02 | Eisai R&D Man Co Ltd | Novel fused imidazole derivative |
WO2005026114A1 (en) * | 2003-09-17 | 2005-03-24 | Pfizer Inc. | Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses |
DOP2006000008A (en) | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | COMBINED THERAPY FOR THE TREATMENT OF DIABETES AND RELATED AFFECTIONS AND FOR THE TREATMENT OF AFFECTIONS THAT IMPROVE THROUGH AN INCREASE IN THE BLOOD CONCENTRATION OF GLP-1 |
CA2622472C (en) | 2005-09-14 | 2013-11-19 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors for treating diabetes |
CN101360723A (en) | 2005-09-16 | 2009-02-04 | 武田药品工业株式会社 | Process for the preparation of pyrimidinedione derivatives |
WO2007112347A1 (en) | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
PE20071221A1 (en) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | GPR119 RECEPTOR AGONISTS IN METHODS TO INCREASE BONE MASS AND TO TREAT OSTEOPOROSIS AND OTHER CONDITIONS CHARACTERIZED BY LOW BONE MASS, AND COMBINED THERAPY RELATED TO THESE AGONISTS |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
US8247438B2 (en) | 2008-02-27 | 2012-08-21 | Neuropill, Inc. | Methods for treating schizophrenia |
EP2108960A1 (en) | 2008-04-07 | 2009-10-14 | Arena Pharmaceuticals, Inc. | Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY |
AR077642A1 (en) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | METABOLISM MODULATORS AND THE TREATMENT OF DISORDERS RELATED TO THE SAME |
JP2013523819A (en) | 2010-04-06 | 2013-06-17 | アリーナ ファーマシューティカルズ, インコーポレイテッド | GPR119 receptor modulators and treatment of disorders related thereto |
KR101871011B1 (en) | 2010-09-22 | 2018-06-25 | 아레나 파마슈티칼스, 인크. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012135570A1 (en) | 2011-04-01 | 2012-10-04 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145361A1 (en) | 2011-04-19 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145604A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
US20140038889A1 (en) | 2011-04-22 | 2014-02-06 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2013055910A1 (en) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2014074668A1 (en) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr119 and the treatment of disorders related thereto |
CA2979033A1 (en) | 2015-03-09 | 2016-09-15 | Intekrin Therapeutics, Inc. | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
US11583516B2 (en) * | 2016-09-07 | 2023-02-21 | Trustees Of Tufts College | Dash inhibitors, and uses related thereto |
US11253508B2 (en) | 2017-04-03 | 2022-02-22 | Coherus Biosciences, Inc. | PPARy agonist for treatment of progressive supranuclear palsy |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991016339A1 (en) | 1990-04-14 | 1991-10-31 | New England Medical Center Hospitals, Inc. | Inhibitors of dipeptidyl-aminopeptidase type iv |
CA2121369C (en) * | 1991-10-22 | 2003-04-29 | William W. Bachovchin | Inhibitors of dipeptidyl-aminopeptidase type iv |
IL111785A0 (en) * | 1993-12-03 | 1995-01-24 | Ferring Bv | Dp-iv inhibitors and pharmaceutical compositions containing them |
TW492957B (en) * | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
US5952301A (en) | 1996-12-10 | 1999-09-14 | 1149336 Ontario Inc. | Compositions and methods for enhancing intestinal function |
-
1999
- 1999-03-23 GB GBGB9906714.2A patent/GB9906714D0/en not_active Ceased
-
2000
- 2000-03-21 UA UA2001096488A patent/UA77644C2/en unknown
- 2000-03-21 MY MYPI20001122A patent/MY135683A/en unknown
- 2000-03-21 PT PT00911186T patent/PT1162969E/en unknown
- 2000-03-21 DK DK00911186T patent/DK1162969T3/en active
- 2000-03-21 US US09/937,032 patent/US7115650B1/en not_active Expired - Fee Related
- 2000-03-21 RU RU2001128507/15A patent/RU2246944C2/en not_active IP Right Cessation
- 2000-03-21 IL IL14556900A patent/IL145569A0/en unknown
- 2000-03-21 CA CA002366911A patent/CA2366911C/en not_active Expired - Fee Related
- 2000-03-21 CN CNB008053243A patent/CN1196483C/en not_active Expired - Fee Related
- 2000-03-21 DE DE60028552T patent/DE60028552T2/en not_active Expired - Lifetime
- 2000-03-21 EP EP00911186A patent/EP1162969B1/en not_active Expired - Lifetime
- 2000-03-21 AT AT00911186T patent/ATE328594T1/en not_active IP Right Cessation
- 2000-03-21 TR TR2001/02647T patent/TR200102647T2/en unknown
- 2000-03-21 AU AU33177/00A patent/AU765912B2/en not_active Ceased
- 2000-03-21 KR KR1020017012144A patent/KR100689951B1/en not_active IP Right Cessation
- 2000-03-21 HU HU0200410A patent/HUP0200410A3/en unknown
- 2000-03-21 CZ CZ20013410A patent/CZ20013410A3/en unknown
- 2000-03-21 ES ES00911186T patent/ES2265918T3/en not_active Expired - Lifetime
- 2000-03-21 PL PL00350797A patent/PL195779B1/en not_active IP Right Cessation
- 2000-03-21 JP JP2000606201A patent/JP2002539243A/en not_active Withdrawn
- 2000-03-21 WO PCT/IB2000/000382 patent/WO2000056296A2/en not_active Application Discontinuation
- 2000-03-21 NZ NZ514449A patent/NZ514449A/en unknown
- 2000-03-21 MX MXPA01009612A patent/MXPA01009612A/en not_active Application Discontinuation
- 2000-03-22 AR ARP000101280A patent/AR023129A1/en unknown
- 2000-03-23 TW TW089105322A patent/TWI244920B/en not_active IP Right Cessation
-
2001
- 2001-09-21 NO NO20014607A patent/NO20014607L/en not_active Application Discontinuation
- 2001-10-02 ZA ZA200108083A patent/ZA200108083B/en unknown
-
2002
- 2002-11-19 HK HK02108361.2A patent/HK1046647B/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2001128507A (en) | Fertility Improving Compositions | |
CA2366911A1 (en) | Compositions for improving fertility | |
RU2001128504A (en) | Growth promoting compositions | |
SG146608A1 (en) | Rapid dissolution formulation of a calcium receptor-active compound | |
RU98111594A (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING FLURBIPROFEN | |
CA2427227A1 (en) | Lactam compound | |
IL212075A0 (en) | Pharmaceutical compositions comprising a combination of a renin inhibitor and at least one therapeutic agent and uses thereof for the manufacture of medicaments for the prevention of, delay of progression of, or treatment of a disease | |
HUP0303876A3 (en) | Preparation of pharmaceutical compositions for treatment of type 2 diabetes using piperidine or tiazolidine, inhibitors of dipeptidyl peptidase iv | |
DE60231298D1 (en) | CAPSAICIN-CONTAINING MISAMENTARY PHARMACEUTICAL COMPOSITIONS | |
SE0104340D0 (en) | New compounds | |
SE0100568D0 (en) | Compounds | |
UA88270C2 (en) | Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes | |
HUP0301194A2 (en) | Pharmaceutical compositions containing combinations of depeptidyl peptidase iv inhibitors and other antidiabetic agents and their use for the treatment of diabete mellitus | |
WO2007009806A3 (en) | Solid dosage formulations of narcotic drugs having improved buccal adsorption | |
RU2008103617A (en) | BISPHOSPHONIC ACIDS INTENDED FOR TREATMENT AND PREVENTION OF OSTEOPOROSIS | |
HUP0001527A2 (en) | Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine | |
AP1745A (en) | Pharmaceutical compositions of amlodipine and atorvastatin. | |
BRPI0413393A (en) | fexofenadine, pharmaceutically acceptable composition, antihistamine treatment method, composition, process for preparing fexofenadine and use of fexofenadine | |
TW200509905A (en) | Pharmaceutical compositions of atorvastatin | |
EA200301040A1 (en) | METHOD OF MANUFACTURE OF PHARMACEUTICAL COMPOSITION OF LOW DOSE | |
SE0102440D0 (en) | New compound | |
SE0100566D0 (en) | Compounds | |
BR0014440A (en) | Oral controlled release formulations | |
SE0000303D0 (en) | Novel compounds | |
SE0101692D0 (en) | Compounds |